ABEONA THERAPEUTICS INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
ABEONA THERAPEUTICS INC. (ABEO) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $116.00 thousand as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes › Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2022-03-31
- 2021-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $116.00K.
- 2021-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $117.00K.
- 2021-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $117.00K.
- 2021-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $117.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One |
|---|---|
| 2021-12-31 | $116.00K 10-K · filed 2022-03-31 |
| 2021-09-30 | $117.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $117.00K 10-Q · filed 2021-07-28 |
| 2021-03-31 | $117.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $117.00K 10-K · filed 2021-03-24 |
| 2020-09-30 | $174.00K 10-Q · filed 2020-11-09 |
| 2019-12-31 | $5.17M 10-K · filed 2020-03-16 |
| 2019-06-30 | $2.59M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $4.03M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $5.38M 10-K · filed 2019-03-18 |
| 2018-09-30 | $86.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $172.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $259.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $346.00K 10-K · filed 2018-03-16 |
| 2016-12-31 | $812.00K 10-K · filed 2017-03-30 |
| 2016-03-31 | $582.00K 10-Q · filed 2016-05-16 |
| 2015-12-31 | $582.00K 10-K · filed 2016-03-30 |
| 2015-09-30 | $582.00K 10-Q · filed 2015-11-16 |
| 2015-03-31 | $465.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $465.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |